Michelle Dipp, MD PhD is the Managing Partner of Biospring Partners which she co-founded after a successful career with global equity firm General Atlantic. Oxford-trained Dr. Michelle Dipp has served on the boards of several life sciences companies including PathAI, Ginko BioWorks, and Immunocure; most recently serving on the board of Abzena. Michelle Dipp can be contacted through her website to inquire about partnerships in the life sciences field.
